Aetiologies and factors associated with mortality among HIV-infected patients at Taraba State Specialist Hospital, Jalingo, Nigeria by unknown
POSTER PRESENTATION Open Access
Aetiologies and factors associated with mortality
among HIV-infected patients at Taraba State
Specialist Hospital, Jalingo, Nigeria
DR Dashe
From Tenth International Congress on Drug Therapy in HIV Infection
Glasgow, UK. 7-11 November 2010
Background
Despite improved access to life-saving antiretroviral
drugs, HIV associated mortality remains high in most
settings in sub-Saharan Africa. Several studies have
shown remarkable temporal distribution of these mor-
tality figures, with a disproportionately higher number
of patients dying within the first few months of com-
mencing HAART.
Purpose of the study
To identify the aetiologies and factors associated with
the deaths of HIV-infected persons enrolled into the
HIV care program at our hospital.
Methods
The study setting is a 230- bed Hospital located in the
north eastern region of Nigeria, with HIV prevalence of
5.2%. HIV services are supported by Management
Sciences for Health through USAID. A cross sectional
study was conducted. The case files of all recorded
deaths were retrieved from the medical records depart-
ment and information on age, sex, date of enrolment,
date of commencement of anti-retroviral drugs, duration
of HAART, W.H.O clinical stage, CD4 cell count and
aetiologies/factors associated with the mortalities were
extracted and analyzed.
Summary of results
A total of 1510 HIV positive patients were enrolled in
our centre (63%F, 47%M) with 758 on HAART. 80
patients (5.2%) had died as at the time of the review.
63% of mortality cases were in patients<40yrs old and
82% presented with WHO stage 3 or 4 disease. The
aetiology of death was TB in 40%, suspected TB in
16.25%, HIV wasting syndrome in 8.75%, septic abortion
in 1.25% and HBV in 1.25%. In 30% of the cases how-
ever, the cause was not ascertained before death. 52% of
mortality cases occurred before HAART commence-
ment, 35% occurred within the first 3 months of
HAART initiation. 60% of deaths occurred in patients
with CD4+T-cell counts<200cells/uL
Conclusions
Advanced HIV disease, severe immunodeficiency, TB
co-morbidity and possibly delay in starting HAART
were found to be associated with increased mortality in
our centre. Thus, strategies to reduce mortality must
include earlier diagnosis of HIV infection and timely
initiation of HAART.
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